Search Results
Search for other papers by Iuri Martin Goemann in
Google Scholar
PubMed
Search for other papers by Vicente Rodrigues Marczyk in
Google Scholar
PubMed
Search for other papers by Mirian Romitti in
Google Scholar
PubMed
Search for other papers by Simone Magagnin Wajner in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
several pathways, particularly in the context of neoplasia. This broad issue has been recently reviewed by our group and others and will not be discussed here ( Davis et al. 2016 , Goemann et al. 2017 ). It should also be noted that rT 3 , which is
Search for other papers by Joanna Grey in
Google Scholar
PubMed
Search for other papers by Kym Winter in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 2 (MEN2) refers collectively to 2 main distinct types of autosomal dominantly inherited neuroendocrine tumour (NET) syndromes ( Barakat et al. 2004 ); MEN type 2A and MEN type 2B (also known as
Search for other papers by Elizabeth Grubbs in
Google Scholar
PubMed
Search for other papers by Daniel Halperin in
Google Scholar
PubMed
Search for other papers by Steven G Waguespack in
Google Scholar
PubMed
Search for other papers by Robert F Gagel in
Google Scholar
PubMed
Overview The multiple endocrine neoplasia syndromes are a varied group of disorders that include multiple endocrine neoplasia types 1 and 2 (MEN 1, MEN 2), von Hippel-Lindau (VHL) disease , Carney complex (CC), hereditary pheochromocytoma
Search for other papers by Iuri Martin Goemann in
Google Scholar
PubMed
Search for other papers by Mirian Romitti in
Google Scholar
PubMed
Search for other papers by Erika L Souza Meyer in
Google Scholar
PubMed
Search for other papers by Simone Magagnin Wajner in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
proliferation and differentiation ( Kress et al . 2009 b , Dentice et al . 2013 ). Indeed, changes in the expression levels of deiodinases are present in several malignant human neoplasias. DIO1 downregulation occurs in renal, lung, hepatic and prostate
Search for other papers by Thomas J Giordano in
Google Scholar
PubMed
) that can predict response to immunotherapy ( Goodman et al . 2017 , Yarchoan et al . 2017 , Steuer & Ramalingam 2018 ), it may be especially relevant and revealing in endocrine neoplasia ( Hellmann et al . 2018 , Kim et al . 2018 a ). Many
Search for other papers by Elizabeth G Grubbs in
Google Scholar
PubMed
Search for other papers by Ronald M Lechan in
Google Scholar
PubMed
Search for other papers by Beth Edeiken-Monroe in
Google Scholar
PubMed
Search for other papers by Gilbert J Cote in
Google Scholar
PubMed
Search for other papers by Chardria Trotter in
Google Scholar
PubMed
Search for other papers by Arthur S Tischler in
Google Scholar
PubMed
Search for other papers by Robert F Gagel in
Google Scholar
PubMed
physician he saw very quickly pieced together a history consistent with a recently identified syndrome, multiple endocrine neoplasia type 2A – the association of medullary thyroid carcinoma (MTC), hyperparathyroidism and pheochromocytoma ( Steiner et al
Search for other papers by Rehannah Borup in
Google Scholar
PubMed
Search for other papers by Maria Rossing in
Google Scholar
PubMed
Search for other papers by Ricardo Henao in
Google Scholar
PubMed
Departments of, Clinical Biochemistry, Endocrinology and Metabolism, Pathology, Herlev Hospital, Pathology, Bispebjerg Hospital, University of Copenhagen, Pathology, ENT Head and Neck Surgery, Odense University Hospital, Bioinformatics Centre, University of Copenhagen, Department of Molecular Pathology and Tumor Pathology, Akita University Graduate School of Medicine, Danish Technical University, Informatics, Rigshospitalet
Search for other papers by Yohei Yamamoto in
Google Scholar
PubMed
Search for other papers by Annelise Krogdahl in
Google Scholar
PubMed
Search for other papers by Christian Godballe in
Google Scholar
PubMed
Departments of, Clinical Biochemistry, Endocrinology and Metabolism, Pathology, Herlev Hospital, Pathology, Bispebjerg Hospital, University of Copenhagen, Pathology, ENT Head and Neck Surgery, Odense University Hospital, Bioinformatics Centre, University of Copenhagen, Department of Molecular Pathology and Tumor Pathology, Akita University Graduate School of Medicine, Danish Technical University, Informatics, Rigshospitalet
Search for other papers by Ole Winther in
Google Scholar
PubMed
Search for other papers by Katalin Kiss in
Google Scholar
PubMed
Search for other papers by Lise Christensen in
Google Scholar
PubMed
Search for other papers by Estrid Høgdall in
Google Scholar
PubMed
Search for other papers by Finn Bennedbæk in
Google Scholar
PubMed
Search for other papers by Finn Cilius Nielsen in
Google Scholar
PubMed
and/or vascular invasion. Moreover, it is difficult to distinguish benign follicular adenoma (FA) from carcinoma. The road to follicular neoplasia is not completely understood. In contrast to the well-defined RET and BRAF mutations found in
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Florian Bösch in
Google Scholar
PubMed
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Katharina Brüwer in
Google Scholar
PubMed
Search for other papers by Annelore Altendorf-Hofmann in
Google Scholar
PubMed
Department of Internal Medicine 4, Ludwig-Maximilians-University Munich, Munich, Germany
Search for other papers by Christoph J Auernhammer in
Google Scholar
PubMed
Department of Internal Medicine 4, Ludwig-Maximilians-University Munich, Munich, Germany
Search for other papers by Christine Spitzweg in
Google Scholar
PubMed
Department of Medicine 3 and Comprehensive Cancer Center, Ludwig-Maximilians-University Munich, Munich, Germany
Search for other papers by C Benedikt Westphalen in
Google Scholar
PubMed
Department of Medicine 3 and Comprehensive Cancer Center, Ludwig-Maximilians-University Munich, Munich, Germany
Search for other papers by Stefan Boeck in
Google Scholar
PubMed
Munich Cancer Registry (MCR) of the Munich Tumour Centre (TZM), Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Ludwig-Maximilians-University Munich, Munich, Germany
Search for other papers by Gabriele Schubert-Fritschle in
Google Scholar
PubMed
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Jens Werner in
Google Scholar
PubMed
Department of Medicine 3 and Comprehensive Cancer Center, Ludwig-Maximilians-University Munich, Munich, Germany
Search for other papers by Volker Heinemann in
Google Scholar
PubMed
Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany
Search for other papers by Thomas Kirchner in
Google Scholar
PubMed
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Search for other papers by Martin Angele in
Google Scholar
PubMed
Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany
Search for other papers by Thomas Knösel in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasia (NENs) are a heterogeneous group of tumors, which can arise from neuroendocrine cells throughout the body. These tumors have an increasing incidence of 2.5–5/100,000 people per year ( Kloppel & Anlauf 2005
Search for other papers by S Felder in
Google Scholar
PubMed
Search for other papers by H Jann in
Google Scholar
PubMed
Search for other papers by R Arsenic in
Google Scholar
PubMed
Search for other papers by T Denecke in
Google Scholar
PubMed
Klinik für Nuklearmedizin, Universitätklinikum Ulm, Ulm, Germany
Search for other papers by V Prasad in
Google Scholar
PubMed
Search for other papers by B Knappe-Drzikova in
Google Scholar
PubMed
Innere Medizin und Gastroenterologie, Asklepios Klinik St. Georg, Asklepios Medical School, Hamburg, Germany
Search for other papers by S Maasberg in
Google Scholar
PubMed
Search for other papers by B Wiedenmann in
Google Scholar
PubMed
Medizinische Klinik 1, Gastroenterologie, Pneumologie und Endokrinologie, Universitätsklinikum der Friedrich-Alexander Universität Erlangen, Erlangen, Germany
Search for other papers by M Pavel in
Google Scholar
PubMed
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Uinversitätsklinikum Münster, Münster, Germany
Search for other papers by A Pascher in
Google Scholar
PubMed
Innere Medizin und Gastroenterologie, Asklepios Klinik St. Georg, Asklepios Medical School, Hamburg, Germany
Search for other papers by U F Pape in
Google Scholar
PubMed
Introduction Gastric neuroendocrine neoplasias (gNENs) are a heterogeneous subgroup of gastroenteropancreatic neuroendocrine neoplasias (GEP-NENs) derived from specialized cells of the diffuse endocrine system and were initially described as
Department of Medical Genetics, Department of Clinical Genetics, University of Cambridge, Cambridge, UK and
Search for other papers by Eamonn R Maher in
Google Scholar
PubMed
studies of HIF2A mutations in pheochromocytoma and paraganglioma have provided novel insights into the role of hypoxic gene response pathways in the pathogenesis of endocrine neoplasia. To date, a number of common themes are emerging. First, most HIF2A